Please check your internet connection and try again.
## Chymosin forte
### Overview
Chymosin forte is a combination product containing chymopapain, papain, and bromelain. These are proteolytic enzymes derived from natural sources, primarily papaya and pineapple. They are intended to break down protein.
### Primary Indications
Chymosin forte is primarily indicated for the **adjunctive treatment of inflammatory conditions** and to **aid in the liquefaction of mucus** in respiratory conditions. It may also be used for **post-operative swelling and bruising**. Evidence supporting these uses is often limited or based on traditional use.
### Adult Dosing
* **General Dosage:** 1-2 tablets orally 3 times daily.
* **Specific dosing can vary significantly based on the severity of the condition and local clinical protocols.**
### Pediatric Dosing
* **Information on pediatric dosing is generally not established or well-documented for chymosin forte.** Use in pediatric populations should be approached with extreme caution and typically under specialist guidance.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are established. Caution is advised due to potential for systemic absorption, though this is generally considered low.
* **Hepatic Impairment:** No specific dose adjustments are established. Caution is advised.
### Contraindications
* Known hypersensitivity to chymopapain, papain, bromelain, or any component of the formulation.
* Active peptic ulcer disease.
* Conditions where protein breakdown could be detrimental (e.g., severe hemorrhagic disorders).
### Adverse Effects
* Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain).
* Allergic reactions, including rash, itching, and rarely anaphylaxis.
* Mouth irritation or sores.
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin):** Theoretically, proteolytic enzymes could increase the risk of bleeding. Closely monitor INR/PTT if co-administered.
* **Antibiotics:** Some evidence suggests proteolytic enzymes may enhance antibiotic penetration to infected sites, but this is not a well-established interaction.
### Monitoring
* **Clinical response:** Assess improvement in inflammatory symptoms, mucus liquefaction, or post-operative swelling.
* **Signs of allergic reaction:** Monitor for rash, itching, or respiratory distress.
* **Bleeding:** In patients on anticoagulants, monitor for signs of increased bleeding.
### Clinical Pearls
* Chymosin forte is often used as an adjunct therapy.
* It is generally recommended to take the medication between meals to maximize absorption and potential systemic effects, although specific recommendations may vary.
* The efficacy of proteolytic enzymes for many indications is not robustly supported by high-quality clinical trials.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines, and exercise clinical judgment when making treatment decisions. Dosing and indications may vary based on individual patient factors, local protocols, and evolving medical knowledge.